The six listed pharmaceutical companies closed the first quarter with a stock market value of €9.5 billion, compared to €10.6 billion at the close of the...
Vall d'Hebron is one of the main public hospitals in Spain. The center received 1.1 million outpatient visits (115,422 more than in 2020), more than 180,600...
Vytrus Biotech closed 2022 with a capitalization of more than €24 million, an increase of 98% since its debut on BME Growth, the SME stock market,...
Thanks to this investment plan, Novartis Italia, which already achieved a turnover of €1.72 billion in 2022, €78 million of which was obtained through exports, further...
Moderna closed 2022 with a profit of $8.36 billion, which represents a decrease of 31% compared to the previous year. Moderna argues this decrease to the...
Eniax also works with some medical centers in Spain, such as the HLA Moncloa University Hospital in Madrid, from Grupo Asisa. Another example of Eniax integration is...
AstraZeneca’s commitment to the Spanish territory can also be seen in the creation of infrastructure since it has allocated a total of €5.5 million for the...
Arthex Biotech is a spin-off of the University of Valencia (UV). Established in September 2019, the company focuses on the development of a treatment for myotonic...
GenomeUp raised, in 2018, €200,000 seed round, of which €60,000 came from LVenture Group and the rest from some Angel Partners Group partners and third-party investors....
The healthcare industry is facing several challenges in adopting new technology, including privacy concerns and regulatory hurdles. However, there are also opportunities for technology to improve...